Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 2 3

Status

Completed 10Terminated 3Recruiting 3Active not recruiting 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Sepsis 1Polycystic Ovary Syndrome 1Neoplasms 1Menstruation Disturbances 1Insulin Resistance 1Hyperandrogenism 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Acupuncture Therapy × Clear all
NCT06344819 2026-05-22

An Acupuncture Study for People At High Risk for Sepsis

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
78 enrolled

Sepsis

NCT06915116 2026-04-14

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
60 enrolled

Menstruation Disturbances, Neoplasms

NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting
303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡